TORONTO - TelAve -- STS Capital Partners is proud to announce the appointment of Steve Slovick as a Managing Director in Puerto Rico. Throughout his 36-year career, Steve has demonstrated his expertise in pricing, commercial launch strategy, business development, market access, and exit strategies within the life science sector.

He started out as Senior Vice President in the early 2000's for PriceSpective, a consulting firm that specialized in strategies to identify, capture, and communicate value for products, portfolios, and companies in the biopharmaceutical industry. PriceSpective was acquired by ICON Plc, where Steve was an important part of the acquisition process unlocking the synergies between the two companies maximizing financial value. His knowledge aligns with our mission at STS Capital, which is centered on helping our clients achieve Extraordinary Exits.

Steve's entrepreneurial spirit led him to establish Jupiter Life Science Consulting in 2015. As CEO and Managing Partner, he led a dedicated team in providing commercial and market access strategies for global pharmaceutical, biotech, and medical device companies. His commitment to addressing complex market access challenges positioned Jupiter as a leading authority in the industry. In 2022, Jupiter was acquired by Red Nucleus where he stayed on as Managing Partner and President MACS to provide guidance and long-term partnership to life science clients worldwide.

More on TelAve News

• Taikan's T-V856S VMC Earns Prestigious 2025 Vogel Global Pioneer Award
• Flick Truck Accident Law Joins the Commercial Vehicle Safety Alliance to Strengthen Truck Safety Advocacy
• PebblePad Announces Global Partnership with Inside Higher Ed and Times Higher Education
• Passion Struck Network Debuts: A Creator-First Platform for Purpose-Driven Podcasting and Human Impact
• The Aligned Woman Is It Well With Your Soul

Drawing from his firsthand experience of orchestrating successful exits, Steve offers a dual perspective as both a former business owner and a sell-side advisor. His comprehensive approach encompasses all aspects of the exit process, making him a valuable ally for business owners seeking a seamless transition.

Steve holds a Bachelor of Science in International Business and a Bachelor of Science in Marketing from the University of Colorado Boulder as well as a Master of Business Administration degree from Pepperdine Graziadio Business School.

"As a Managing Director at STS Capital Partners, Steve brings a wealth of experience and a track record of success to the table. With a career spanning decades, he has consistently demonstrated his ability to drive value and transformative initiatives within the pharmaceutical sector, aligning perfectly with our commitment to delivering maximum value and Extraordinary Exits for our clients." Sean Friday, CEO of STS Capital Partners.

About STS Capital Partners:

More on TelAve News

• Jonathan Malveaux Named Newest Member of Forbes Business Council
• NFL Midseason 2025: Who's for Real and Who's Faking It?
• Silver Ball, Golden Heart: Dallas-Area Pinball Wizards Flip for Charity at Side Quest Arcade
• Sweet Beginnings: Sugar Queen Dessert Shop Opens in the Colony Ridge Community
• World Record Established: Million-Dollar Bilibin Screen Sells at Shapiro Auctions

STS Capital Partners is a global sell-side M&A firm like no other. We are expert guides for private, founder, and entrepreneurial business owners on the journey to achieving an Extraordinary Exit™. Our extensive global relationships, world-class team, and proven deal process bring international strategic buyers and investors to the table who deliver maximum financial value. As a result, we help clients fulfill bigger ambitions in life and leave lasting legacies by inspiring charitable donations through our Success to Significance™ program with a goal of raising billions of dollars in new philanthropic and impact capital.

Visit www.stscapital.com.